Skip to main content

Articles

Page 58 of 90

  1. Patients with chronic kidney disease are at increased risk of cystic kidney disease that requires imaging monitoring in many cases. However, these same patients often have contraindications to contrast-enhance...

    Authors: Emily Hueywen Chang, Wui Kheong Chong, Sandeep Kumar Kasoji, Julia Rose Fielding, Ersan Altun, Lee B. Mullin, Jung In Kim, Jason Peter Fine, Paul Alexander Dayton and Wendy Kimryn Rathmell
    Citation: BMC Nephrology 2017 18:266
  2. To evaluate the effect of perfusion status on elasticity measurements of different compartments in the kidney using shear wave elastography (SWE) both in vivo and ex vivo.

    Authors: Xiaona Liu, Na Li, Tao Xu, Fang Sun, Rui Li, Qimin Gao, Lianxiang Chen and Chaoyang Wen
    Citation: BMC Nephrology 2017 18:265
  3. To investigate the impact of timing the initiation of renal replacement therapy (RRT) on clinical outcomes in critically ill patients with acute kidney injury (AKI), focusing on the randomized controlled trial...

    Authors: Xiao-mei Yang, Guo-wei Tu, Ji-li Zheng, Bo Shen, Guo-guang Ma, Guang-wei Hao, Jian Gao and Zhe Luo
    Citation: BMC Nephrology 2017 18:264
  4. Tubulointerstitial injury is important to predict the progression of lupus nephritis (LN). Urine neutrophil gelatinase-associated lipocalin (NGAL) has been reported to detect worsening LN disease activity. Thu...

    Authors: Bancha Satirapoj, Chagriya Kitiyakara, Asada Leelahavanichkul, Yingyos Avihingsanon and Ouppatham Supasyndh
    Citation: BMC Nephrology 2017 18:263
  5. Thrombotic microangiopathy (TMA) is a serious, sometimes life-threatening disorder marked by the presence of endothelial injury and microvascular thrombi. Drug-induced thrombotic microangiopathy (DI-TMA) is on...

    Authors: Sean A. Hebert, Timothy P. Bohan, Christian L. Erikson and Rita D. Swinford
    Citation: BMC Nephrology 2017 18:262
  6. Immunoglobulin G4-related kidney disease characterized by immunoglobulin G4-positive plasma cell-rich tubulointerstitial nephritis has distinctive serological and radiological findings. Renal prognosis is good...

    Authors: Hiroyuki Ono, Taichi Murakami, Akira Mima, Eriko Shibata, Masanori Tamaki, Sakiya Yoshimoto, Sayo Ueda, Fumi Kishi, Seiji Kishi, Takashi Kawanaka, Motokazu Matsuura, Kojiro Nagai, Hideharu Abe, Masashi Harada and Toshio Doi
    Citation: BMC Nephrology 2017 18:261
  7. The significance of IgM deposits in glomerular mesangium has been controversial since they were first described due to the variations in the both the definitions used and described impact on clinical outcome. ...

    Authors: Sandra Juozapaite, Rimante Cerkauskiene, Arvydas Laurinavicius and Augustina Jankauskiene
    Citation: BMC Nephrology 2017 18:260
  8. The use of the Internet for searching and sharing health information and for health care interactions may have a great potential for Renal Transplant Recipients (RTR). This study aims to determine the characte...

    Authors: Yosra Mouelhi, Marine Alessandrini, Vanessa Pauly, Bertrand Dussol and Stéphanie Gentile
    Citation: BMC Nephrology 2017 18:259
  9. Objective of the study is to assess prevalence and survival among end stage renal disease patients with restless legs syndrome (RLS) within a national database (USRDS).

    Authors: Joseph J. DeFerio, Usha Govindarajulu, Amarpali Brar, Daniel Cukor, Kathleen G. Lee and Moro O. Salifu
    Citation: BMC Nephrology 2017 18:258
  10. Since diabetes mellitus (DM) is the leading cause of end stage renal disease (ESRD), this study aimed to develop a 5-year ESRD risk prediction model among Chinese patients with Type 2 DM (T2DM) in primary care.

    Authors: Eric Yuk Fai Wan, Daniel Yee Tak Fong, Colman Siu Cheung Fung, Esther Yee Tak Yu, Weng Yee Chin, Anca Ka Chun Chan and Cindy Lo Kuen Lam
    Citation: BMC Nephrology 2017 18:257
  11. Non-steroidal anti-inflammatory drugs (NSAIDs) are a common cause of adverse drug events (ADEs), but renal risks of NSAIDs are less well quantified than gastrointestinal and cardiac risks. This paper reports a...

    Authors: Xinyu Zhang, Peter T Donnan, Samira Bell and Bruce Guthrie
    Citation: BMC Nephrology 2017 18:256
  12. Renal dysfunction is a common problem in the HIV+ population, due to the effect of both the HIV virus and the several classes of ARV drugs such as tenofovir (TDF). It is also known that the presence of renal d...

    Authors: Katia Falasca, Marta Di Nicola, Italo Porfilio, Claudio Ucciferri, Elisabetta Schiaroli, Chiara Gabrielli, Daniela Francisci and Jacopo Vecchiet
    Citation: BMC Nephrology 2017 18:255
  13. Patient engagement and patient-centered care are critical in optimally managing patients with end-stage renal disease (ESRD). Understanding patient preferences is a key element of patient-centered care and sha...

    Authors: Brett Hauber, John Caloyeras, Joshua Posner, Deborah Brommage, Vasily Belozeroff and Kerry Cooper
    Citation: BMC Nephrology 2017 18:254
  14. Patient engagement in end-stage renal disease (ESRD) is expected to result in a more patient-centered approach to care that aligns with patients’ values, preferences, and goals for treatment. Nevertheless, no ...

    Authors: Brett Hauber, John Caloyeras, Joshua Posner, Deborah Brommage, Spiros Tzivelekis and Allan Pollock
    Citation: BMC Nephrology 2017 18:253
  15. Advances in technology and the ability to interrogate disease pathogenesis using systems biology approaches are exploding. As exemplified by the substantial progress in the personalized diagnosis and treatment...

    Authors: Daniel A. Muruve, Michelle C. Mann, Kevin Chapman, Josee F. Wong, Pietro Ravani, Stacey A. Page and Hallgrimur Benediktsson
    Citation: BMC Nephrology 2017 18:252
  16. The main reason for anemia in renal failure patients is the insufficient erythropoietin production by the kidneys. Beside erythropoietin deficiency, in vitro studies have incriminated uremic toxins in the path...

    Authors: Stanislas Bataille, Marion Pelletier, Marion Sallée, Yvon Berland, Nathalie McKay, Ariane Duval, Stéphanie Gentile, Yosra Mouelhi, Philippe Brunet and Stéphane Burtey
    Citation: BMC Nephrology 2017 18:251

    The Publisher Correction to this article has been published in BMC Nephrology 2017 18:306

  17. Hemodialysis (HD) patients have increased risk of cardiovascular disease (CVD). Impaired stem cell health and adipocytokine metabolism may play important roles in the complex pathophysiological mechanisms of C...

    Authors: Abdullah Ozkok, Riza Atas, Suzan Adin Cinar, Akar Yilmaz, Esin Aktas, Gunnur Deniz and Alaattin Yildiz
    Citation: BMC Nephrology 2017 18:250
  18. Chronic refractory hypotension (IDH, intradialytic hypotension) is a rare but serious problem encountered in patients on hemodialysis. Patients with chronic hypotension are often disqualified by transplant tea...

    Authors: Ewa Ignacak, Dominik Cieniawski, Alina Bętkowska-Prokop, Czesław Osuch, Marek Kuźniewski and Władysław Sułowicz
    Citation: BMC Nephrology 2017 18:248
  19. Acute kidney injury (AKI) is common in patients with multiple myeloma (MM). Whether serum free light chain (sFLC) measurements can distinguish between myeloma and other causes of AKI requires confirmation to g...

    Authors: Jennifer L. J. Heaney, John P. Campbell, Punit Yadav, Ann E. Griffin, Meena Shemar, Jennifer H. Pinney and Mark T. Drayson
    Citation: BMC Nephrology 2017 18:247
  20. Chronic Kidney Disease (CKD) is a worldwide public health problem. There are few studies in Latin America, especially in primary care settings. Our objective was to determine the prevalence, stages, and associ...

    Authors: Percy Herrera-Añazco, Alvaro Taype-Rondan, María Lazo-Porras, E. Alberto Quintanilla, Victor Manuel Ortiz-Soriano and Adrian V. Hernandez
    Citation: BMC Nephrology 2017 18:246
  21. The application of mycophenolate mofetil (MMF) in treating patients with immunoglobulin A nephropathy (IgAN) remains uncertain. This update meta-analysis was performed to re-evaluate the therapeutic potential ...

    Authors: Bing Du, Ye Jia, Wenhua Zhou, Xu Min, Lining Miao and Wenpeng Cui
    Citation: BMC Nephrology 2017 18:245
  22. The epidemiology and outcomes of acute kidney injury (AKI) in prevalent non-renal solid organ transplant recipients is unknown.

    Authors: Girish N. Nadkarni, Kinsuk Chauhan, Achint Patel, Aparna Saha, Priti Poojary, Sunil Kamat, Shanti Patel, Rocco Ferrandino, Ioannis Konstantinidis, Pranav S. Garimella, Madhav C. Menon and Charuhas V. Thakar
    Citation: BMC Nephrology 2017 18:244
  23. Hemolytic uremic syndrome (HUS) can occur as a primary process due to mutations in complement genes or secondary to another underlying disease. HUS sometimes occurs in the setting of glomerular diseases, and i...

    Authors: Joseph L. Alge, Scott E. Wenderfer, John Hicks, Mir Reza Bekheirnia, Deborah A. Schady, Jamey S. Kain and Michael C. Braun
    Citation: BMC Nephrology 2017 18:243
  24. The Literature on rhabdomyolysis in the HIV-positive population is sparse and limited. We aimed to explore the incidence, patient characteristics, etiologies and outcomes of rhabdomyolysis in a cohort of HIV-p...

    Authors: Sahar H. Koubar, Michelle M. Estrella, Rugmini Warrier, Richard D. Moore, Gregory M. Lucas, Mohamed G. Atta and Derek M. Fine
    Citation: BMC Nephrology 2017 18:242
  25. Prediction models in autosomal dominant polycystic kidney disease (ADPKD) are useful in clinical settings to identify patients with greater risk of a rapid disease progression in whom a treatment may have more...

    Authors: Laura Girardat-Rotar, Julia Braun, Milo A. Puhan, Alison G. Abraham and Andreas L. Serra
    Citation: BMC Nephrology 2017 18:241
  26. Asians have among the highest prevalence of chronic kidney disease (CKD) or end-stage renal disease in the world. A risk score capable of identifying high risk individuals at the primary care level could allow...

    Authors: Krittika Saranburut, Prin Vathesatogkit, Nisakron Thongmung, Anchalee Chittamma, Somlak Vanavanan, Tuangrat Tangstheanphan, Piyamitr Sritara and Chagriya Kitiyakara
    Citation: BMC Nephrology 2017 18:240
  27. Monoclonal immunoglobulin deposition disease (MIDD) is characterized by the non-amyloid deposition of monoclonal immunoglobulin fragments in the basement membranes. Heavy chain deposition disease (HCDD) is a t...

    Authors: Takayuki Katsuno, Shige Mizuno, Masatsuna Mabuchi, Naotake Tsuboi, Atsushi Komatsuda and Shoichi Maruyama
    Citation: BMC Nephrology 2017 18:239
  28. Because chronic fluid volume overload is associated with higher mortality, we tested whether blood-volume monitored regulation of ultrafiltration and dialysate conductivity (UCR) and/or regulation of ultrafilt...

    Authors: Marlies Antlanger, Peter Josten, Michael Kammer, Isabella Exner, Katharina Lorenz-Turnheim, Manfred Eigner, Gernot Paul, Renate Klauser-Braun, Gere Sunder-Plassmann, Marcus D. Säemann and Manfred Hecking
    Citation: BMC Nephrology 2017 18:238
  29. Toxic epidermal necrolysis (TEN) is a rare life-threatening condition almost exclusively attributed to drugs. The main etiologic factors for TEN are sulphonamides, anticonvulsants, and antibiotics; however, th...

    Authors: Katsuaki Kasahara, Yoshimitsu Gotoh, Yoshiyuki Kuroyanagi and China Nagano
    Citation: BMC Nephrology 2017 18:237
  30. Cardiovascular disease is the major cause of death in patients with end-staged kidney disease (ESRD). Most ESRD patients have systemic inflammation, and increasing the risk of cardiovascular event. Endotoxin d...

    Authors: Chien-Chin Hsu, Tsui-Shan Wei, Chien-Cheng Huang and Yi-Ming Chen
    Citation: BMC Nephrology 2017 18:235
  31. Heterozygous mutations in the gene encoding renin (REN) cause autosomal dominant tubulointerstitial kidney disease (ADTKD), early-onset anaemia and hyperuricaemia; only four different mutations have been describe...

    Authors: Rhian L. Clissold, Helen C. Clarke, Olivera Spasic-Boskovic, Kim Brugger, Stephen Abbs, Coralie Bingham and Charles Shaw-Smith
    Citation: BMC Nephrology 2017 18:234
  32. Tubular biomarkers have been regarded as emerging and promising markers for early diagnosis of diabetic kidney disease (DKD). The study was to determine the diagnostic capabilities of tubular biomarkers (urina...

    Authors: Xian-Fei Zeng, Dong-Xue Lu, Jun-Min Li, Yun Tan, Zhuo Li, Lei Zhou, Zeng-Qian Xi, Shu-Miao Zhang and Wei Duan
    Citation: BMC Nephrology 2017 18:233
  33. Intermedin [IMD, adrenomedullin-2 (ADM-2)] attenuates renal fibrosis by inhibition of oxidative stress. However, the precise mechanisms remain unknown. Heme oxygenase-1 (HO-1), an antioxidant agent, is associa...

    Authors: Xi Qiao, Lihua Wang, Yanhong Wang, Xiaole Su, Yufeng Qiao, Yun Fan and Zhiqiang Peng
    Citation: BMC Nephrology 2017 18:232
  34. An association between serum complement levels and poor renal prognosis in patients with immunoglobulin A nephropathy (IgAN) remains controversial.

    Authors: Min Pan, Ji Zhang, Zhanyuan Li, Lingwei Jin, Yu Zheng, Zhihong Zhou, Su Zhen and Guoyuan Lu
    Citation: BMC Nephrology 2017 18:231
  35. Rare diseases may elude diagnosis due to unfamiliarity of the treating physicians with the specific disorder. Yet, advances in genetics have tremendously enhanced our ability to establish specific and sometime...

    Authors: Stephen Benedict Walsh, Robert Unwin, Robert Kleta, William van’t Hoff, Paul Bass, Khalid Hussain, Sian Ellard and Detlef Bockenhauer
    Citation: BMC Nephrology 2017 18:230
  36. The current practice concerning timing, mode, and dose of renal replacement therapy (RRT) in patients with metformin-associated lactic acidosis (MALA) with renal failure remains unknown. To investigate whether...

    Authors: Hung-Chieh Yeh, I-Wen Ting, Ching-Wei Tsai, Jenn-Yu Wu and Chin-Chi Kuo
    Citation: BMC Nephrology 2017 18:229
  37. Physical and psychological symptoms are among main manifestations of Chronic Kidney Disease (CKD). This study aimed to assess the symptom burden and self-perceived severity of symptoms among CKD patients livin...

    Authors: Sameera Senanayake, Nalika Gunawardena, Paba Palihawadana, Palitha Bandara, Rashan Haniffa, R Karunarathna and Priyantha Kumara
    Citation: BMC Nephrology 2017 18:228
  38. According to renal M type phospholipase A2 receptor (PLA2R) immunohistochemistry, idiopathic membranous nephropathy (IMN) could be categorized into PLA2R-associated and non-PLA2R-associated IMN. We conducted a re...

    Authors: Jia Wang, Qionghong Xie, Zhuxing Sun, Ningxin Xu, Yan Li, Liang Wang, Shaojun Liu, Jun Xue and Chuan-Ming Hao
    Citation: BMC Nephrology 2017 18:227
  39. The aim of this study was to identify the optimal equation that accurately estimates the glomerular filtration rate (GFR) and the chronic kidney disease (CKD) stage in the Chinese population.

    Authors: Xiao-Hua Chi, Gui-Ping Li, Quan-Shi Wang, Yong-Shuai Qi, Kai Huang, Qian Zhang and Yao-ming Xue
    Citation: BMC Nephrology 2017 18:226
  40. The histone deacetylase (HDAC) inhibitor, which has potential effects on epigenetic modifications, had been reported to attenuate renal fibrosis. CD4+ forkhead box P3 (FOXP3)+ T regulatory (Treg) cells may be con...

    Authors: Wen-Pyng Wu, Yi-Giien Tsai, Tze-Yi Lin, Ming-Ju Wu and Ching-Yuang Lin
    Citation: BMC Nephrology 2017 18:225
  41. Surgical thrombectomy in the context of acute renal vein thrombosis (RVT) post-transplantation has had limited success, with considerable variation in the surgical techniques used. Unfortunately, it is usually...

    Authors: Paraish Misra, Anish Kirpalani, General Leung, Paraskevi A. Vlachou, Jason Y. Lee, Serge Jothy, Jeffrey Zaltzman and Darren A. Yuen
    Citation: BMC Nephrology 2017 18:224
  42. Continuous renal replacement therapy (CRRT) is the recommended modality of dialysis for critically ill patients with hemodynamic instability. Yet there remains significant variability in how CRRT is prescribed...

    Authors: Michael Heung, Sean M. Bagshaw, Andrew A. House, Luis A. Juncos, Robin Piazza and Stuart L. Goldstein
    Citation: BMC Nephrology 2017 18:222
  43. The proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor evolocumab is a low-density lipoprotein (LDL)-lowering drug with a new mechanism, which is currently available in Japan. Here, for the first ...

    Authors: Yuki Awanami, Makoto Fukuda, Yasunori Nonaka, Tsuyoshi Takashima, Keiichiro Matsumoto, Masatora Yamasaki, Motoaki Miyazono and Yuji Ikeda
    Citation: BMC Nephrology 2017 18:221
  44. Congenital nephrotic syndrome (CNS) is a rare disorder caused by various structural and developmental defects of glomeruli. It occurs typically as an isolated kidney disorder but associates sometimes with othe...

    Authors: Jiro Kino, Hiroyasu Tsukaguchi, Takahisa Kimata, Huan Thanh Nguyen, Yorika Nakano, Noriko Miyake, Naomichi Matsumoto and Kazunari Kaneko
    Citation: BMC Nephrology 2017 18:220

    The Erratum to this article has been published in BMC Nephrology 2017 18:271

  45. Osteoprotegerin (OPG) is a glycoprotein that plays an important regulatory role in the skeletal, vascular, and immune system. It has been shown that OPG predicts chronic kidney disease (CKD) in diabetic patien...

    Authors: Stella Bernardi, Barbara Toffoli, Fleur Bossi, Riccardo Candido, Elisabetta Stenner, Renzo Carretta, Fabio Barbone and Bruno Fabris
    Citation: BMC Nephrology 2017 18:219
  46. Urinary biomarkers of kidney injury are presumed to reflect renal tubular damage. However, their concentrations may be influenced by other factors, such as hematuria or pyuria. We sought to examine what non-in...

    Authors: Girish N. Nadkarni, Steven G. Coca, Allison Meisner, Shanti Patel, Kathleen F. Kerr, Uptal D. Patel, Jay L. Koyner, Amit X. Garg, Heather Thiessen Philbrook, Charles L. Edelstein, Michael Shlipak, Joe El-Khoury and Chirag R. Parikh
    Citation: BMC Nephrology 2017 18:218
  47. Physical, cognitive and psychosocial functioning are frequently impaired in dialysis patients and impairment in these domains relates to poor outcome. The aim of this analysis was to compare the prevalence of ...

    Authors: I. N. van Loon, M. L. Bots, F. T. J. Boereboom, M. P. C. Grooteman, P. J. Blankestijn, M. A. van den Dorpel, M. J. Nubé, P. M. Ter Wee, M. C. Verhaar and M. E. Hamaker
    Citation: BMC Nephrology 2017 18:217

Affiliated with

Annual Journal Metrics

  • 2022 Citation Impact
    2.3 - 2-year Impact Factor
    2.8 - 5-year Impact Factor
    1.064 - SNIP (Source Normalized Impact per Paper)
    0.746 - SJR (SCImago Journal Rank)

    2023 Speed
    28 days submission to first editorial decision for all manuscripts (Median)
    158 days submission to accept (Median)

    2023 Usage 
    3,053,628 downloads
    3,742 Altmetric mentions 

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal